Tradestie Institutional Equity Comparison Engine
NDRA vs DARE โ Head-to-Head Terminal
6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.
Pillar 1 Executive Scorecard & Category Winner Tally
NDRA Overall Edge
NDRA Captures Institutional Edge (2โ1 Pillars ยท 4โ4 Matrix Metrics)
Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to ENDRA Life Sciences Inc. Common Stock (NDRA) driven by superior Growth & Margin, Momentum & Technical while DARE counters with relative strength in Valuation. Fundamentally, NDRA trades at N/M Forward P/E with 0.0% operating margin (+0.0% YoY revenue) versus DARE at 1.3x Forward P/E and -813.4% operating margin (+499.6% YoY). In options structure, NDRA sits in UNCLASSIFIED (N/A IV; Dealer Gamma Walls on Pro) against DARE sits in UNCLASSIFIED (N/A IV; Dealer Gamma Walls on Pro).
Valuation Winner
DARE
NDRA N/M vs DARE 1.3x Fwd P/E
Growth & Margin Winner
NDRA
Op Margin 0.0% vs -813.4% ยท YoY +0.0% vs +499.6%
Momentum & Technical Winner
NDRA
1Y -32.7% vs -69.1% ยท 52W Pos 37% vs 0%
Options & Structure Winner
Tie
UNCLASSIFIED (N/A IV) vs UNCLASSIFIED (N/A IV)
NDRA
NASDAQ
ENDRA Life Sciences Inc. Common Stock
Electromedical & Electrotherapeutic Apparatus
$4.42
+0.23% 1D
Market Cap
$6.6M
1M Return
-6.75%
1Y Return
-32.72%
Forward P/E
N/M
Unified AI Score
44.7 / 100
HOLD
Tech 35.0
Fund 46.0
Flow 50.0
Mom 60.0
DARE
NASDAQ
Dare Bioscience, Inc. Common Stock
Pharmaceutical Preparations
$0.58
-11.13% 1D
Market Cap
$12.9M
1M Return
-19.38%
1Y Return
-69.09%
Forward P/E
1.3x
Unified AI Score
45.7 / 100
HOLD
Tech 33.0
Fund 52.0
Flow 50.0
Mom 64.0
Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)
1Y Indexed Return:
NDRA -32.72%
DARE -69.09%
Spread: +36.37 pp (NDRA Lead)
Pillar 3 Multi-Year Annual Revenue & Operating Margin Trajectory (USD)
| Period | NDRA Revenue | DARE Revenue | NDRA Op. Margin | DARE Op. Margin | Margin Edge |
|---|---|---|---|---|---|
| FY2014 | N/A | $0M | N/A | -29177.5% | DARE |
| FY2016 | $0M | $0M | -347.5% | -82.3% | DARE |
| FY2017 | $0M | N/A | -1315.6% | N/A | NDRA |
| FY2018 | $0M | N/A | -146080.5% | N/A | NDRA |
| FY2022 | N/A | $10M | N/A | -313.9% | DARE |
| FY2023 | N/A | $0M | N/A | -1101.9% | DARE |
| FY2024 | N/A | $0M | N/A | -239692.2% | DARE |
| FY2025 | N/A | $0M | N/A | -1315.5% | DARE |
Pillar 4 Head-to-Head Fundamental & Valuation Matrix
| Institutional Metric | NDRA | DARE | Criterion | Row Winner |
|---|---|---|---|---|
| Market Capitalization Scale | $6.6M | $12.9M | Larger Scale | Tie |
| Trailing P/E Ratio Valuation | N/M | 1.3x | Lower Multiple | DARE |
| Forward P/E Ratio Valuation | N/M | 1.3x | Lower Multiple | DARE |
| Revenue Growth (YoY) Growth | +0.0% | +499.6% | Higher Growth | DARE |
| Operating Margin (TTM) Profitability | 0.0% | -813.4% | Higher Margin | NDRA |
| Net Profit Margin Profitability | 0.0% | 0.0% | Higher Margin | Tie |
| Return on Equity (ROE) Capital Efficiency | -152.0% | -2543.1% | Higher ROE | NDRA |
| 52-Week Range Position Momentum | 37% ($3โ$7) | 0% ($1โ$4) | Stronger Trend | NDRA |
| Beta / 30D Volatility Risk Regime | 0.71ฮฒ ยท 48% Vol | 1.40ฮฒ ยท 62% Vol | Lower Realized Risk | NDRA |
| Unified Institutional Score Composite Signal | 44.7 / 100 (HOLD) | 45.7 / 100 (HOLD) | Higher Composite | DARE |
Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor
Full NDRA vs DARE Buy Guide
NDRA
UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor
Pro Only
Call Wall Magnet
Pro Only
IV Percentile
N/A
IV Regime
Unclassified
DARE
UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor
Pro Only
Call Wall Magnet
Pro Only
IV Percentile
N/A
IV Regime
Unclassified
Pillar 6 90-Day Technical & R&D Innovation Disclosures
Corporate R&D & Foundry Tracker
Neither NDRA nor DARE registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.